A detailed history of Four Thought Financial, LLC transactions in Incyte Corp stock. As of the latest transaction made, Four Thought Financial, LLC holds 1,000 shares of INCY stock, worth $59,020. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$59,020
Previous $76,000 11.84%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Nov 12, 2021

SELL
$76.02 - $100.5 $1,900 - $2,512
-25 Reduced 2.44%
1,000 $81,000
Q4 2020

Nov 12, 2021

BUY
$80.74 - $97.7 $82,758 - $100,142
1,025 New
1,025 $89,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.